Adults and children ages 4 to 65 may be eligible to participate in a clinical study for peanut allergies.

Study participants will receive study-related care at no cost.

See if you are eligible for this paid study by filling out this form.
You will be contacted by our staff as soon as possible.

FARE in collaboration with ALK Pharmaceuticals, are working on a study to assess the safety and tolerability of a once-daily sublingual immunotherapy (SLIT) tablet for peanut allergy. The peanut SLIT-tablet is being developed for peanut-allergic patients to reduce allergic reactions that may occur following accidental exposure to peanut. By desensitizing patients to peanut protein, tolerance is increased and consequently protects against allergic reactions upon accidental peanut exposure.

Read on

Why participate in clinical research? All of the medicines you currently take for your health were first studied in clinical trials before the FDA approved them.  It is a great way to help your community, while getting close care and monitoring by doctors you know.

See other active clinical trials in Normal, IL or Springfield, IL here.

Page updated: January 2024